Open Access

REVIEW

Engendered nanoparticles for treatment of brain tumors

SOROUSH SOLEYMANI¹, MOHAMMAD DOROUDIAN^2,*, MAHDIEH SOEZI^3,4, ALI BELADI⁵, KIARASH ASGARI², ASO MOBARAKSHAHI², ARYANA AGHAEIPOUR², RONAN MACLOUGHLIN^6,7,8,*

1 Department of Cell and Molecular Biology, School of Biological Sciences, University of Leicester, Leicester, LE1 7RH, UK
2 Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, 15719-14911, Iran
3 Cancer Epidemiology Research Center, Aja University of Medical Sciences, Tehran, 14117-18541, Iran
4 Medical Biotechnology Research Center, Aja University of Medical Sciences, Tehran, 14117-18541, Iran
5 Department of Life Sciences, Faculty of Natural Sciences, Imperial College London, London, SW7 2AZ, UK
6 School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland (RCSI), Dublin, D02 YN77, Ireland
7 Research and Development, Science and Emerging Technologies, Aerogen Ltd., Galway Business Park, Galway, H91 HE94, Ireland
8 School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland

* Corresponding Authors: MOHAMMAD DOROUDIAN. Email: ; RONAN MACLOUGHLIN. Email: